???global.info.a_carregar???
Joana Trindade Mourato Lopes Ribeiro. Publicou 9 artigos em revistas especializadas. Atua na(s) área(s) de Ciências Médicas e da Saúde com ênfase em Medicina Clínica com ênfase em Oncologia.
Identification

Personal identification

Full name
Joana Trindade Mourato Lopes Ribeiro

Citation names

  • Ribeiro, Joana
  • Joana M Ribeiro

Author identifiers

Ciência ID
B81E-11D5-3D63
ORCID iD
0000-0001-7947-672X

Email addresses

  • joana-mourato.ribeiro@gustaveroussy.fr (Professional)
  • joanaribeiro.onc@gmail.com (Personal)

Telephones

Telephone
  • 962980135 (Personal)

Addresses

  • Avenida Brasília, 1400-038, Lisboa, Lisboa , Portugal (Professional)
  • 114 Rue Edouard Vaillant, 94800, Villejuif, Paris, France (Professional)

Websites

Knowledge fields

  • Medical and Health Sciences - Clinical Medicine - Oncology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
French Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Education
Degree Classification
2016/10/01 - 2022/10/01
Ongoing
 Doutoramente em Medicina (Doutoramento)
Major in Clinical Research
Universidade Nova de Lisboa, Portugal
2017/09 - 2018/11
Concluded
 Bioinformatics Curricular Unit (Especialização pós-licenciatura)
Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical, Portugal
2017/06 - 2018/06
Concluded
 Global Clinical Scholars Research Training (GCSRT) Program (Especialização pós-licenciatura)
Major in Clinical Research
Harvard Medical School, United States
2005/04/05 - 2011/11/09
Concluded
 Medicina - Especialidade de Oncologia Médica (Especialização pós-licenciatura)
Hospital de Santa Maria, Portugal
 19
1998/09/01 - 2004/06/01
Concluded
 Medicina (Licenciatura)
Major in Master degree in Medicine
Universidade de Lisboa Faculdade de Medicina, Portugal
 Final score 16 out of 20.
Affiliation

Science

Category
Host institution 		Employer
2010/10/04 - 2011/01/04 Research Trainee (Research) Istituto Europeo di Oncologia, Italy
Istituto Europeo di Oncologia, Italy

Others

Category
Host institution 		Employer
2012/11/01 - Current Medical Oncologist and Clinical Researcher Fundação Champalimaud, Portugal
2011/10/16 - 2012/10/31 Medical Oncologist and Medical Researcher Hospital de Santa Maria, Portugal
2005/03/01 - 2011/10/10 General residency ( Ano Comum / Foundation year) Hospital de Santa Maria, Portugal
Projects

Grant

Designation Funders
2014/07 - 2016/06 Relative effectivity of aromatase inhibitors versus tamoxifen in patients with early breast cancer
Provided by PTCRIS: 135669
 Fundação para a Ciência e a Tecnologia

Contract

Designation Funders
2020/06 - 2021/06 Registo nacional de doentes ONcológicos com Coronavirus disease 2019 (COVID-19) - ONCOVID.PT
634
Researcher
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
 Associação para a Inovação e Desenvolvimento da FCT
Ongoing
Outputs

Publications

Book
  1. Ajithkumar, Thankamma; Barrett, Ann; Hatcher, Helen; Jefferies, Sarah Jane. Oxford Desk Reference: Oncology - Breast Cancer. Oxford University Press. 2021.
    Published • 10.1093/med/9780198745440.001.0001
Book chapter
  1. Volovat, Simona; Ribeiro, Joana Mourato; Konsoulova, Assia; Paluch-Shimon, Shani; Cardoso, Fatima. "Management of Advanced Breast Cancer in Young Women: What’s New in Systemic Treatment". In Breast Cancer in Young Women, 127-142. Springer International Publishing, 2020.
    10.1007/978-3-030-24762-1_12
  2. Eunice Carrasquinha; João Santinha; Alexander Mongolin; Maria Lisitskiya; Joana Ribeiro; Fátima Cardoso; Celso Matos; Leonardo Vanneschi; Nickolas Papanikolaou. "Regularization Techniques in Radiomics: A Case Study on the Prediction of pCR in Breast Tumours and the Axilla". 271-281. Springer International Publishing, 2020.
    10.1007/978-3-030-63061-4_24
  3. Castillo-Martin, Mireia; Ribeiro, Joana. "Case Studies: Molecular Pathology Perspective and Impact on Oncologic Patients’ Management". In Molecular and Cell Biology of Cancer, 191-216. Springer International Publishing, 2019.
    10.1007/978-3-030-11812-9_10
  4. Ribeiro, Joana. "Metastatic Breast Cancer". In Management of Breast Diseases, 451-474. Springer Berlin Heidelberg, 2016.
    Published
  5. Azul, Jamile Gonçalves Serra. "Tratamento sistémico do cancro da mama HER2 positivo". In 100 perguntas chave no cancro de mama, 309-320. Portugal: PERMANYER PORTUGAL, 2015.
    10.22533/at.ed.77519081025
Conference paper
  1. Almeida, Cátia; Mendes, Raquel; Ribeiro, Joana Mourato; Cardoso, Maria João; Cardoso, Fátima; Ferreira, Miguel Godinho; Fior, Rita. "Abstract P1-03-04: Zebrafish xenografts as a fast screening platform for bevacizumab impact on tumor growth, angiogenesis and micrometastasis in breast cancer". Paper presented in San Antonio Breast Cancer Symposium, San Antonio, Texas, 2019.
    10.1158/1538-7445.sabcs19-p1-03-04
Conference poster
  1. Ribeiro, Joana. "BRCA mutations in young women – overview of a tertiary Breast Unit". Paper presented in 3rd ESO-ESMO Breast Cancer in Young Women International Conference (BCY3), 2016.
  2. Ribeiro, Joana. "Variation in the chemotherapy use patterns for patients with stage I breast cancer: a multi-institutional study.". Paper presented in 18th ECCO – 40th ESMO European Cancer Congress, 2015.
  3. Cazzaniga, Marina E; Valentini, Annalisa; Gallina, Francesca; Riva, Francesca; Crippa, Alessandra; Tagliabue, Marco; Cicchiello, Federica; Cortinovis, Diego; Bidoli, Paolo. "Patterns of care and relative effectiveness of aromatase inhibitors compared to tamoxifen in pts with early breast cancer: a multi-institutional study.". Paper presented in 18th ECCO – 40th ESMO European Cancer Congress, 2015.
    10.1158/1538-7445.sabcs14-p2-12-05
  4. Ribeiro, Joana. "The use of trastuzumab in patients with early breast cancer: a multi-institutional study.". Paper presented in 18th ECCO – 40th ESMO European Cancer Congress,, 2015.
  5. Ribeiro, Joana. "Role of serum HER2 (sHER2) levels to predict acquisition of HER2 overexpression in metastatic lesions of breast cancer patients with HER2 negative/unknown at the primary site.". Paper presented in 2011 ASCO Annual Meeting., 2011.
  6. Ribeiro, Joana. "Correlation between hormonal receptors and HER2 status of primary and metastatic breast cancer according to the metastatic organ involved". Paper presented in 7th European Breast Cancer Conference, 2010.
  7. Ribeiro, Joana. "Fulvestrant in metastatic breast cancer previously treated with aromatase inhibitors". Paper presented in 6th European Breast Cancer Conference., 2008.
Journal article
  1. Martina Pagliuca; Julie Havas; Emilie Thomas; Youenn Drouet; Davide Soldato; Maria Alice Franzoi; Joana Ribeiro; et al. "Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model". JNCI: Journal of the National Cancer Institute (2025): https://doi.org/10.1093/jnci/djae222.
    10.1093/jnci/djae222
  2. Maria Alice Franzoi; Arlindo R. Ferreira; Antoine Lemaire; Joseph Rodriguez; Jessica Grosjean; Joana M. Ribeiro; Laura Polastro; et al. "Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium". The Lancet Regional Health - Europe (2024): https://doi.org/10.1016/j.lanepe.2024.101005.
    10.1016/j.lanepe.2024.101005
  3. J.M. Ribeiro; J. Dixon-Douglas; F. André. "Moving to ultra-short therapy to cure patients with cancer: a solution for sustainable cancer care". ESMO Open (2024): https://doi.org/10.1016/j.esmoop.2024.102238.
    10.1016/j.esmoop.2024.102238
  4. Quentin Blampey; Nadège Bercovici; Charles-Antoine Dutertre; Isabelle Pic; Joana Mourato Ribeiro; Fabrice André; Paul-Henry Cournède. "A biology-driven deep generative model for cell-type annotation in cytometry". Briefings in Bioinformatics (2023): https://doi.org/10.1093/bib/bbad260.
    10.1093/bib/bbad260
  5. Joana Ribeiro. "Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France". JAMA Network Open 5 9 (2022): e2231170-e2231170. http://dx.doi.org/10.1001/jamanetworkopen.2022.31170.
    10.1001/jamanetworkopen.2022.31170
  6. Joana Ribeiro. "Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: A systematic review". Critical Reviews in Oncology/Hematology 177 (2022): 103773-103773. http://dx.doi.org/10.1016/j.critrevonc.2022.103773.
    10.1016/j.critrevonc.2022.103773
  7. Joana Ribeiro. "ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast". Future Oncology 18 22 (2022): 2383-2392. http://dx.doi.org/10.2217/fon-2022-0358.
    10.2217/fon-2022-0358
  8. Rebelo de Almeida, Cátia; Mendes, Raquel Valente; Pezzarossa, Anna; Gago, Joaquim; Carvalho, Carlos; Alves, António; Nunes, Vitor; et al. "Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy". Communications Biology 3 1 (2020): http://dx.doi.org/10.1038/s42003-020-1015-0.
    10.1038/s42003-020-1015-0
  9. Amgad, Mohamed; Stovgaard, Elisabeth Specht; Balslev, Eva; Thagaard, Jeppe; Chen, Weijie; Dudgeon, Sarah; Sharma, Ashish; et al. "Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group". npj Breast Cancer 6 1 (2020): http://dx.doi.org/10.1038/s41523-020-0154-2.
    10.1038/s41523-020-0154-2
  10. Wuerstlein, Rachel; Barrios, Carlos; Lambertini, Matteo; Tsang, Janice; Ribeiro, Joana M.; Haidinger, Renate. "Highlights from ABC5: Bridging the Gap". Breast Care 15 1 (2020): 75-81. http://dx.doi.org/10.1159/000505900.
    10.1159/000505900
  11. Ferreira, Arlindo R.; Ribeiro, Joana; Miranda, Ana; Mayer, Alexandra; Passos-Coelho, José Luís; Brito, Margarida; Fernandes, João; et al. "Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early Breast Cancer: A Multicenter Cohort Study". Clinical Breast Cancer 19 5 (2019): e654-e667. http://dx.doi.org/10.1016/j.clbc.2019.06.003.
    10.1016/j.clbc.2019.06.003
  12. Ferreira, Arlindo R.; Palha, Ana; Correia, Lurdes; Filipe, Pedro; Rodrigues, Vasco; Miranda, Ana; André, Rosário; et al. "Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: A multi-institutional observational study". The Breast 37 (2018): 107-113. http://dx.doi.org/10.1016/j.breast.2017.11.003.
    Published • 10.1016/j.breast.2017.11.003
  13. Wuerstlein, Rachel; Ettl, Johannes; Haidinger, Renate; Lueftner, Diana; Ribeiro, Joana; Tsang, Janice. "Highlights from ABC4 - Bridging the Gap". Breast Care 12 6 (2017): 415-419. http://dx.doi.org/10.1159/000485867.
    Published • 10.1159/000485867
  14. R Ferreira A; Palha A; Correia L; Filipe P; Rodrigues V; Costa L; Miranda A; et al. "Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional Portuguese cohort study.". (2016): http://europepmc.org/abstract/med/27468923.
    10.1016/j.breast.2016.07.004
  15. Ribeiro J; Cardoso MJ. "Highlights from the Tenth European Breast Cancer Conference (EBCC10), Amsterdam, 9-11 March 2016.". (2016): http://europepmc.org/abstract/med/27350789.
    10.3332/ecancer.2016.644
  16. Aseyev O; Ribeiro JM; Cardoso F. "Review on the clinical use of eribulin mesylate for the treatment of breast cancer.". (2016): http://europepmc.org/abstract/med/26809667.
    10.1517/14656566.2016.1146683
  17. Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F. "Breast cancer under age 40: a different approach.". (2015): http://europepmc.org/abstract/med/25796377.
    10.1007/s11864-015-0334-8
  18. da Fonseca Reis Silva D; Ribeiro JM. "Infracentimetric HER-2 positive breast tumours-review of the literature.". (2015): http://europepmc.org/abstract/med/26635897.
    10.3332/ecancer.2015.593
  19. Ribeiro, Joana; Cardoso, Fátima. "O Registo Oncológico Regional Sul e a Investigação Clinica em Portugal: Desafios e Oportunidades". Acta Médica Portuguesa 27 3 (2014): 282. http://dx.doi.org/10.20344/amp.5589.
    Open access • Published • 10.20344/amp.5589
  20. Ribeiro J; Sousa B; Cardoso F. "Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.". (2013): http://europepmc.org/abstract/med/26217109.
    10.1016/j.ejcsup.2013.07.029
  21. Vasconcelos AL; Nunes B; Duarte C; Mendonça V; Ribeiro J; Jorge M; Monteiro Grillo I. "Tamoxifen in breast cancer ipse dixit in uterine malignant mixed Müllerian tumor and sarcoma-A report of 8 cases and review of the literature.". (2013): http://europepmc.org/abstract/med/24416561.
    10.1016/j.rpor.2013.06.005
  22. Ribeiro JT; Macedo LT; Curigliano G; Fumagalli L; Locatelli M; Dalton M; Quintela A; et al. "Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?". (2012): http://europepmc.org/abstract/med/21896541.
    10.1093/annonc/mdr382
  23. Macedo LT; Ribeiro J; Curigliano G; Fumagalli L; Locatelli M; Carvalheira JB; Quintela A; Bertelli S; De Cobelli O. "Multidisciplinary approach in the treatment of patients with small cell bladder carcinoma.". (2011): http://europepmc.org/abstract/med/21555200.
    10.1016/j.ejso.2011.04.005
  24. Luís, Inês Vaz; Casimiro, Sandra; Ribeiro, Joana; Costa, Luís. "Zoledronic Acid: Its Use in the Treatment of Breast Cancer". Clinical Medicine Insights: Therapeutics 2 (2010): CMT.S2353. http://dx.doi.org/10.4137/cmt.s2353.
    Published • 10.4137/cmt.s2353

Other

Other output
  1. HER2 Inhibition and Clinical Achievements. 2013. Berta Sousa; Joana Ribeiro; Fatima Cardoso. http://dx.doi.org/10.1201/b15944-4.
    10.1201/b15944-4
Activities

Association member

Society Organization name Role
2017/06 - Current Sociedade Portuguesa de Senologia Membro (513)
2017 - Current ASPIC –Portuguese Association for Cancer Research Membro
2015/06/01 - Current European Society of Medical Oncology Membro 52388
2014/06 - Current European Association for Cancer Research (EACR) Membro

Committee member

Activity description
Role 		Institution / Organization
2017/11 - Current Membro da Direção da Sociedade Portuguesa de Oncologia
Member
 Sociedade Portuguesa de Oncologia , Portugal

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2010/03 - 2013/07 Adjunct lecturer of Oncobiology Medicina (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2009/09 - 2012/09 Adjuvant lecturer of Oncopharmacology Imagem Médica e Radioterapia (Licenciatura) Instituto Politécnico de Lisboa Escola Superior de Tecnologia da Saúde de Lisboa, Portugal
Distinctions

Award

2020 Menção Honrosa
Prémio BIAL de Medicina Clínica 2020, Portugal